Stock AFME AFFLUENT MEDICAL
Add to a list
To use this feature you must be a member
Log inSign up

All News Affluent Medical

Equities

AFME

FR0013333077

Market Closed - Euronext Paris
Other stock markets
 11:27:19 2024-05-31 am EDT 		5-day change 1st Jan Change
1.8 EUR +1.12% Intraday chart for Affluent Medical +4.65% -2.44%
Apr. 25 Affluent Medical SA Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Mar. 13 AFFLUENT MEDICAL : Invest Securities reiterates its opinion CF

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Affluent Medical : 2023 financial results and update on clinical activities under development.
EQ
Affluent Medical SA Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Affluent Medical announces coverage initiation of its stock by Gilbert Dupont – Société Générale Group.
EQ
Affluent Medical : announces coverage initiation of its stock by TP ICAP Midcap.
PU
Affluent Medical announces coverage initiation of its stock by TP ICAP Midcap.
EQ
AFFLUENT MEDICAL : Invest Securities reiterates its opinion
CF
Affluent Medical: 1st human implantation of 'Artus
CF
Affluent Medical announces successful first-in-human implantation of its artificial sphincter Artus for the treatment of stress urinary incontinence.
EQ
Affluent Medical : Excellent valve performance at 1 year follow up and rising recognition of Epygon biomimetic mitral valve.
EQ
Affluent Medical Obtains Bridge Financing to Fund Operations
MT
Affluent Medical closes €3.5 million bridge via capital increase from key shareholders.
EQ
Affluent Medical : Half-year liquidity contract statement for Affluent Medical.
EQ
Affluent Medical SA announced that it has received ?3.5 million in funding
CI
Affluent Medical : Pre-submission dossier for the 510(k) of medical device KaliosTM filed with FDA for review.
EQ
Affluent Medical : Start of the European pilot study with the Artus medical device for the treatment of urinary incontinence.
EQ
Affluent Medical announces coverage initiation of its stock by Portzamparc – Groupe BNP Paribas.
EQ
Affluent Medical : H1 2023 results. Major advances in clinical programs. Extension of cash horizon to February 2024.
EQ
Affluent Medical SA: H1 2023 RESULTS - Major advances in clinical programs - Extension of cash horizon to February 2024
EQ
Affluent Medical SA Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Affluent Medical: positive results in cardiology
CF
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AFME Stock
  4. News Affluent Medical